Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
Zuojie Li, Qingpeng Wang, Linming Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 17920-17935
Closed Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

A Self‐Delivery Nanodrug Simultaneously Inhibits COX‐2/PGE2 Mediated Inflammation and Downregulates PD‐L1 to Boost Photoimmunotherapy
Jinmei Lai, Peiling Chen, Qun‐Ying Shi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 3
NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer
Leandro L. Coutinho, Elise L. Femino, Ana Luisa González, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6103-6103
Open Access | Times Cited: 3
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
Bin Liu, Bing‐Bing Liang, Wan-Di Cao, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 49
Open Access | Times Cited: 3
Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial–Mesenchymal Transition Suppression, and Immune Activation Properties
Ming Zhang, Yan Chen, Shuaiqi Feng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16416-16434
Closed Access | Times Cited: 3
Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and Apoptosis
Meng Wang, Guoxiu Cao, Junjie Zhou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13587-13606
Closed Access | Times Cited: 9
Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 266, pp. 116095-116095
Closed Access | Times Cited: 9
Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity
Angelico D. Aputen, Maria George Elias, Jayne Gilbert, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2181-2181
Open Access | Times Cited: 2
Ciclopirox platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses
Suying Li, Shuaiqi Feng, Yan Chen, et al.
Journal of Inorganic Biochemistry (2024) Vol. 260, pp. 112696-112696
Closed Access | Times Cited: 2
Older but Stronger: Development of Platinum-Based Antitumor Agents and Research Advances in Tumor Immunity
Jianing Liu, Yi Cao, Bin Hu, et al.
Inorganics (2023) Vol. 11, Iss. 4, pp. 145-145
Open Access | Times Cited: 6
Highly potent Platinum(IV) complexes with multiple-bond ligands targeting mitochondria to overcome cisplatin resistance
Bo Fang, Xue Chen, Xingui Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115235-115235
Closed Access | Times Cited: 5
Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents
Angelico D. Aputen, Maria George Elias, Jayne Gilbert, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2460-2460
Open Access | Times Cited: 5
Platinum(IV)–Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple‐Negative Breast Cancer Models
Javier E. López‐Hernández, Nazia Nayeem, José P. Cerón‐Carrasco, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 59
Open Access | Times Cited: 5
Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action
Daniil Spector, Anna Bubley, Елена К. Белоглазкина, et al.
Russian Chemical Reviews (2023) Vol. 92, Iss. 10, pp. RCR5096-RCR5096
Closed Access | Times Cited: 5
Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand
Fengfan Liu, Yang Chen, Shaoguang Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114673-114673
Closed Access | Times Cited: 8
Gold(I) Complexes Based on Nonsteroidal Anti-Inflammatory Derivatives as Multi-Target Drugs against Colon Cancer
Javier Sáez, Javier Quero, María Jesús Rodríguez-Yoldi, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 42, pp. 19769-19782
Open Access | Times Cited: 1
Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity
Yan Chen, Shuaiqi Feng, Ming Zhang, et al.
Journal of Inorganic Biochemistry (2024) Vol. 262, pp. 112766-112766
Closed Access | Times Cited: 1
Ptxplatin: a multifunctional Pt(iv) antitumor prodrug
Ran Zhang, Yueyue Zhang, Liumei Tang, et al.
Inorganic Chemistry Frontiers (2022) Vol. 9, Iss. 20, pp. 5252-5266
Closed Access | Times Cited: 6
Prodrug Approach: NSAID Conjugates of Platinum Compounds as Anti-Cancer Agents
B Nija
Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) (2023) Vol. 32, Iss. 3, pp. 1-13
Open Access | Times Cited: 2
Pt(IV) derivatives of cisplatin and oxaliplatin bearing EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116
Zhong‐Ying Ma, Xiaojing Ding, Zhen-Zhen Zhu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 3239-3247
Closed Access
Platinum‐Metformin Conjugates Acting as Promising PD‐L1 Inhibitors through the AMP‐Activated Protein Kinase Mediated Lysosomal Degradation Pathway
Bin Liu, Bing‐Bing Liang, Wan-Di Cao, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 49
Closed Access
Halogen cation-promoted and solvent-regulated electrophilic cyclization for the regioselective synthesis of 3-haloquinolines and 3-halospirocyclohexadienones
Jianming Li, Chengxiao Liu, Zihan Zhao, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 11, pp. 2440-2446
Closed Access
A Series of Ligustrazine Platinum(Iv) Complexes with Potent Anti-Proliferative and Anti-Metastatic Properties by Causing Chemotherapeutic and Immunotherapeutic Effects
Yan Chen, Linming Li, Zhifang Liu, et al.
(2023)
Closed Access
Anti-Inflammatory Drug Repurposing for Intranasal Delivery: Ketoprofen Nanoemulgel Development for the Treatment of Glioma
Patrícia C. Pires, Mafalda Correia, Francisco Veiga, et al.
(2023), pp. 20-20
Open Access
Previous Page - Page 2

Scroll to top